{"id":20237,"date":"2025-03-14T09:59:03","date_gmt":"2025-03-14T16:59:03","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=20237"},"modified":"2025-11-06T09:27:17","modified_gmt":"2025-11-06T17:27:17","slug":"charter-challenge-community-care-and-recovery-act","status":"publish","type":"post","link":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/","title":{"rendered":"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em>Le fran\u00e7ais suit<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The <em>Community Care and Recovery Act, <\/em>passed by the Ontario government on Dec. 4, 2024, introduced location restrictions on supervised consumption services, prohibited municipalities and local boards from applying for federal exemptions to decriminalize personal drug possession, and restricted them from establishing or supporting supervised consumption services or participating in federally-funded prescribed alternatives programs without approval from Ontario\u2019s Minister of Health.&nbsp;&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As a result of the Act, 10 supervised consumption sites that collectively offer overdose prevention, connection to supports, services and treatment to people at risk of death from toxic drugs have received notice from the province to halt operations as of April 1, 2025.&nbsp; The Act prohibits the establishment and operation of supervised consumption sites within 200 metres of schools and childcare facilities, in addition to other premises that may be prescribed. If left unchallenged, it will severely curtail harm reduction service delivery in Ontario, putting more people at risk of drug poisoning, reducing community safety, increasing stigma towards people who use drugs, and eliminating proven lifesaving services amid a public health crisis.&nbsp;&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/tngcommunityto.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">The Neighbourhood Group Community Services<\/a>, alongside two individuals who access supervised consumption services, have filed a Charter challenge regarding the constitutionality of this legislation. The applicants argue the Act violates:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Section 7 rights to life, liberty and security of the person due to the denial and restriction of access to services that save lives and reduce transmission of infectious disease;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Section 12 rights to not be subjected to cruel and unusual punishment due to the risk of increased death, disease and other harms in a degrading and dehumanizing manner incompatible with dignity; and&nbsp;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Section 15 rights to equality and freedom from discrimination due to denial of medical treatment for people with substance use disability.&nbsp;&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The applicants also argue the Act perpetuates stigmatizing and discriminatory stereotypes about people who use drugs and people diagnosed with \u201csubstance use disorder\u201d that suggest they are not worthy of care needed for survival.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">On March 24-25 2025, the court will be asked to consider whether the <em>Community Care and Recovery Act <\/em>unduly violates the Charter rights of people who use drugs. As part of this, the court will be asked to consider whether closing and restricting the availability of supervised consumption services will actually further the Act\u2019s<em> <\/em>stated purpose to \u201cprotect children, families and people struggling with addiction by restricting supervised consumption sites, in line with its belief that addictions treatment is the best way to achieve lasting recovery.\u201d Further, the court will be asked to consider how stigma against people who use drugs may impact this assessment.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Supervised consumption services are an evidence-based initiative that reduce fatal and non-fatal overdoses and increase engagement with health and social services for people who use drugs. Since 2018 in Ontario, there have been <a href=\"https:\/\/odprn.ca\/occ-opioid-and-suspect-drug-related-death-data\/\" target=\"_blank\" rel=\"noreferrer noopener\">23,596<\/a> suspected drug-related deaths. Equity-denied groups such as <a href=\"https:\/\/odprn.ca\/research\/publications\/opioid-first-nations-annual-update-2013-2021\/\" target=\"_blank\" rel=\"noreferrer noopener\">Indigenous people<\/a> and <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37845790\/\" target=\"_blank\" rel=\"noreferrer noopener\">people who experience housing precarity<\/a> are disproportionately represented in toxic drug overdose deaths. Supervised consumption sites in Ontario have successfully managed more than <a href=\"https:\/\/health-infobase.canada.ca\/supervised-consumption-sites\/\" target=\"_blank\" rel=\"noreferrer noopener\">23,965 overdoses<\/a> without any fatalities, despite the increasingly toxic composition of the unregulated drug supply. People accessing supervised consumption services in Ontario have received <a href=\"https:\/\/health-infobase.canada.ca\/supervised-consumption-sites\/\" target=\"_blank\" rel=\"noreferrer noopener\">589,962 service referrals<\/a> for other forms of health and social support, including addiction treatment, withdrawal management, primary healthcare, HIV and Hepatitis C testing and treatment, housing, and administrative support such as securing identification.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>For additional information and background see:<\/strong>&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.hivlegalnetwork.ca\/site\/wp-content\/uploads\/2024\/12\/2024-12-09-Issued-Notice-of-Application-The-Neighbourhood-Group.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Issued Notice of Application &#8211; Dec 9 2024<\/a>&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.canlii.org\/en\/ca\/scc\/doc\/2011\/2011scc44\/2011scc44.html\" target=\"_blank\" rel=\"noreferrer noopener\">Insite Supreme Court of Canada Ruling &#8211; Sept 30 2011<\/a>&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In 2011, a Supreme Court ruling found that the refusal to grant legal amnesty for supervised consumption services was a violation of Section 7 Charter rights.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">___________________________________________________________<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>La contestation judiciaire de la <em>Loi sur les soins et le r\u00e9tablissement en milieu communautaire<\/em> de l\u2019Ontario en bref<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La <em>Loi sur les soins et le r\u00e9tablissement en milieu communautaire<\/em>, adopt\u00e9e par le gouvernement de l\u2019Ontario le 4\u202fd\u00e9cembre\u202f2024, met en place des restrictions relatives \u00e0 l\u2019emplacement des services de consommation supervis\u00e9e, interdit aux municipalit\u00e9s et aux conseils locaux de demander des exemptions f\u00e9d\u00e9rales visant \u00e0 d\u00e9criminaliser la possession personnelle de drogues et les emp\u00eache d\u2019\u00e9tablir ou de soutenir des services de consommation supervis\u00e9e ou encore de participer \u00e0 des programmes f\u00e9d\u00e9raux de prescription de m\u00e9dicaments rempla\u00e7ant certaines drogues sans l\u2019approbation de la ministre de la Sant\u00e9 de l\u2019Ontario. En raison de l\u2019adoption de cette loi, 10\u202fsites de consommation supervis\u00e9e qui assurent collectivement la pr\u00e9vention des surdoses, la mise en relation avec des ressources ainsi que la fourniture de services et de soins \u00e0 des milliers de personnes risquant de mourir \u00e0 cause de drogues toxiques ont re\u00e7u l\u2019ordre de la province de cesser leurs activit\u00e9s d\u00e8s le 1<sup>er<\/sup>\u202favril\u202f2025. La Loi interdit d\u2019ouvrir ou de faire fonctionner des sites de consommation supervis\u00e9e \u00e0 moins de 200\u202fm\u00e8tres d\u2019une \u00e9cole ou d\u2019un centre de garde d\u2019enfants ainsi que d\u2019autres types de lieux prescrits. Si rien n\u2019est fait, cette loi entravera gravement la fourniture de services de r\u00e9duction des m\u00e9faits dans la province, ce qui aura pour effet d\u2019augmenter les risques de d\u00e9c\u00e8s par intoxication aux drogues, de r\u00e9duire le sentiment de s\u00e9curit\u00e9 dans la population, de renforcer les pr\u00e9jug\u00e9s sur les personnes qui consomment des drogues et d\u2019\u00e9liminer des services \u00e9prouv\u00e9s qui sauvent des vies, en pleine crise de sant\u00e9 publique.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les <a href=\"https:\/\/tngcommunityto.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">services communautaires du Neighbourhood Group<\/a>, avec deux personnes qui ont recours aux services de consommation supervis\u00e9e, contestent la constitutionnalit\u00e9 de la Loi. Selon eux, la Loi contrevient aux articles suivants de la <em>Charte canadienne des droits et libert\u00e9s<\/em>\u202f:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>L\u2019article\u202f7 \u2013 Droit \u00e0 la vie, \u00e0 la libert\u00e9 et la s\u00e9curit\u00e9 de la personne, \u00e9tant donn\u00e9 l\u2019interdiction ou la restriction de l\u2019acc\u00e8s \u00e0 des services qui sauvent des vies et qui pr\u00e9viennent la transmission de maladies infectieuses.&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>L\u2019article\u202f12 \u2013 Traitements ou peines cruels et inusit\u00e9s, \u00e9tant donn\u00e9 le risque accru de d\u00e9c\u00e8s, de maladie et d\u2019autres pr\u00e9judices d\u00e9gradants et d\u00e9shumanisants, incompatibles avec le maintien de la dignit\u00e9.&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>L\u2019article\u202f15 \u2013 Droit \u00e0 l\u2019\u00e9galit\u00e9, sans discrimination, \u00e9tant donn\u00e9 le refus de traitements m\u00e9dicaux \u00e0 des personnes ayant un handicap li\u00e9 \u00e0 l\u2019usage de substances psychoactives.&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Les demandeurs font \u00e9galement valoir que la Loi perp\u00e9tue des st\u00e9r\u00e9otypes stigmatisants et discriminatoires au sujet des personnes qui consomment des drogues et de celles qui ont un diagnostic de \u00ab\u202ftrouble li\u00e9 \u00e0 l\u2019usage d\u2019une substance psychoactive\u202f\u00bb, st\u00e9r\u00e9otypes qui encouragent la croyance selon laquelle ces personnes ne m\u00e9ritent pas les soins n\u00e9cessaires \u00e0 leur survie.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les 24 et 25\u202fmars\u202f2025, nous demanderons \u00e0 la Cour de d\u00e9terminer si la <em>Loi sur les soins et le r\u00e9tablissement en milieu communautaire<\/em> enfreint ind\u00fbment les droits des personnes qui consomment des drogues. Dans le cadre de cette contestation, il sera demand\u00e9 \u00e0 la Cour d\u2019\u00e9tablir si la fermeture des services de consommation supervis\u00e9e et les restrictions d\u2019acc\u00e8s \u00e0 ces services r\u00e9pondent r\u00e9ellement \u00e0 l\u2019objectif de la Loi, \u00e0 savoir \u00ab\u202fprot\u00e9ger les enfants, les familles ainsi que les personnes qui luttent contre la toxicomanie en limitant les sites de consommation supervis\u00e9e, conform\u00e9ment \u00e0 [la] conviction que le traitement de la toxicomanie est le meilleur moyen de parvenir \u00e0 un r\u00e9tablissement durable\u202f\u00bb. Il sera \u00e9galement demand\u00e9 \u00e0 la Cour de tenir compte de l\u2019incidence potentielle des pr\u00e9jug\u00e9s concernant les personnes qui consomment des drogues dans son analyse.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les sites de consommation supervis\u00e9e sont des initiatives fond\u00e9es sur les faits qui r\u00e9duisent le nombre de surdoses mortelles et non mortelles et qui am\u00e9liorent la relation des personnes consommatrices de drogues avec les services de sant\u00e9 et les services sociaux. Depuis 2018, en Ontario, il y a eu <a href=\"https:\/\/odprn.ca\/occ-opioid-and-suspect-drug-related-death-data\/\" target=\"_blank\" rel=\"noreferrer noopener\">23 596<\/a> d\u00e9c\u00e8s soup\u00e7onn\u00e9s d\u2019\u00eatre li\u00e9s \u00e0 la drogue. Par ailleurs, il est \u00e0 noter que les groupes en qu\u00eate d\u2019\u00e9quit\u00e9 comme les <a href=\"https:\/\/odprn.ca\/research\/publications\/opioid-first-nations-annual-update-2013-2021\/\" target=\"_blank\" rel=\"noreferrer noopener\">Autochtones<\/a> et les <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37845790\/\" target=\"_blank\" rel=\"noreferrer noopener\">personnes en situation de logement pr\u00e9caire<\/a> sont surrepr\u00e9sent\u00e9s dans les d\u00e9c\u00e8s par surdose de drogues toxiques. Les sites de consommation supervis\u00e9e de la province ont pris en charge plus de <a href=\"https:\/\/sante-infobase.canada.ca\/services-consommation-supervisee\/\" target=\"_blank\" rel=\"noreferrer noopener\">23\u202f965\u202fcas de surdose<\/a> sans que survienne un seul d\u00e9c\u00e8s, malgr\u00e9 la composition de plus en plus toxique des drogues non r\u00e9glement\u00e9es. Les personnes qui fr\u00e9quentent les services de consommation supervis\u00e9e de l\u2019Ontario ont re\u00e7u <a href=\"https:\/\/sante-infobase.canada.ca\/services-consommation-supervisee\/\" target=\"_blank\" rel=\"noreferrer noopener\">589\u202f962\u202frecommandations<\/a> \u00e0 d\u2019autres services de sant\u00e9 et de soutien social, notamment pour le traitement des d\u00e9pendances, la gestion du sevrage, les soins de sant\u00e9 primaires, le d\u00e9pistage et le traitement du VIH et de l\u2019h\u00e9patite\u202fC, la recherche de logement et les d\u00e9marches administratives comme l\u2019obtention de pi\u00e8ces d\u2019identit\u00e9.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pour en savoir plus\u202f:<\/strong>&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.hivlegalnetwork.ca\/site\/wp-content\/uploads\/2024\/12\/2024-12-09-Issued-Notice-of-Application-The-Neighbourhood-Group.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Avis de requ\u00eate \u2013 9\u202fd\u00e9cembre\u202f2024<\/a>&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.canlii.org\/fr\/ca\/csc\/doc\/2011\/2011csc44\/2011csc44.html\" target=\"_blank\" rel=\"noreferrer noopener\">D\u00e9cision de la Cour supr\u00eame du Canada concernant le site de consommation supervis\u00e9e Insite \u2013 30\u202fseptembre\u202f2011<\/a>&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">En 2011, un jugement de la Cour supr\u00eame du Canada a \u00e9tabli que le refus d\u2019accorder une exemption juridique \u00e0 des services de consommation supervis\u00e9e constituait une violation de l\u2019article\u202f7 de la <em>Charte canadienne des droits et libert\u00e9s<\/em>.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le fran\u00e7ais suit The Community Care and Recovery Act, passed by the Ontario government on Dec. 4, 2024, introduced location restrictions on supervised consumption services, prohibited municipalities and local boards from applying for federal exemptions to decriminalize personal drug possession, and restricted them from establishing or supporting supervised consumption services or participating in federally-funded prescribed [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":21605,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-20237","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0 - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0 - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Le fran\u00e7ais suit The Community Care and Recovery Act, passed by the Ontario government on Dec. 4, 2024, introduced location restrictions on supervised consumption services, prohibited municipalities and local boards from applying for federal exemptions to decriminalize personal drug possession, and restricted them from establishing or supporting supervised consumption services or participating in federally-funded prescribed [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-14T16:59:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-06T17:27:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Canadian Drug Policy Coalition\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/\"},\"author\":{\"name\":\"Canadian Drug Policy Coalition\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\"},\"headline\":\"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0\",\"datePublished\":\"2025-03-14T16:59:03+00:00\",\"dateModified\":\"2025-11-06T17:27:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/\"},\"wordCount\":1578,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png\",\"articleSection\":[\"All\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/\",\"name\":\"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0 - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png\",\"datePublished\":\"2025-03-14T16:59:03+00:00\",\"dateModified\":\"2025-11-06T17:27:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/#primaryimage\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/charter-challenge-community-care-and-recovery-act\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\",\"name\":\"Canadian Drug Policy Coalition\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"caption\":\"Canadian Drug Policy Coalition\"},\"description\":\"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/author\\\/canadian-drug-policy-coalition\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0 - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/","og_locale":"fr_FR","og_type":"article","og_title":"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0 - Canadian Drug Policy Coalition","og_description":"Le fran\u00e7ais suit The Community Care and Recovery Act, passed by the Ontario government on Dec. 4, 2024, introduced location restrictions on supervised consumption services, prohibited municipalities and local boards from applying for federal exemptions to decriminalize personal drug possession, and restricted them from establishing or supporting supervised consumption services or participating in federally-funded prescribed [&hellip;]","og_url":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2025-03-14T16:59:03+00:00","article_modified_time":"2025-11-06T17:27:17+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png","type":"image\/png"}],"author":"Canadian Drug Policy Coalition","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Canadian Drug Policy Coalition","Dur\u00e9e de lecture estim\u00e9e":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/#article","isPartOf":{"@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/"},"author":{"name":"Canadian Drug Policy Coalition","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30"},"headline":"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0","datePublished":"2025-03-14T16:59:03+00:00","dateModified":"2025-11-06T17:27:17+00:00","mainEntityOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/"},"wordCount":1578,"commentCount":0,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png","articleSection":["All"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/","url":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/","name":"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0 - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/#primaryimage"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png","datePublished":"2025-03-14T16:59:03+00:00","dateModified":"2025-11-06T17:27:17+00:00","breadcrumb":{"@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/#primaryimage","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/Blog-Overview-of-the-Charter-challenge-of-Ontarios-Community-Care-and-Recovery-Act-.png","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/drugpolicy.ca\/fr\/charter-challenge-community-care-and-recovery-act\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Overview of the Charter challenge of Ontario\u2019s Community Care and Recovery Act\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30","name":"Canadian Drug Policy Coalition","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","caption":"Canadian Drug Policy Coalition"},"description":"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice","url":"https:\/\/drugpolicy.ca\/fr\/author\/canadian-drug-policy-coalition\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/20237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=20237"}],"version-history":[{"count":4,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/20237\/revisions"}],"predecessor-version":[{"id":20262,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/20237\/revisions\/20262"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/21605"}],"wp:attachment":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=20237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=20237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=20237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}